• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-去氧野尻霉素和苯并三唑的混合物优先诱导丁酰胆碱酯酶(BuChE)的抑制,而不是乙酰胆碱酯酶(AChE)。

A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE).

机构信息

Department of Chemistry, Bioscience and Environmental Engineering, Faculty of Science and Technology, University of Stavanger, Stavanger, Norway.

Department of Organic Chemistry, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

J Enzyme Inhib Med Chem. 2022 Dec;37(1):2395-2402. doi: 10.1080/14756366.2022.2117912.

DOI:10.1080/14756366.2022.2117912
PMID:36065944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9467581/
Abstract

The synthesis of four heterodimers in which the copper(I)-catalysed azide-alkyne cycloaddition was employed to connect a 1-deoxynojirimycin moiety with a benzotriazole scaffold is reported. The heterodimers were investigated as inhibitors against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The heterodimers displayed preferential inhibition (> 9) of BuChE over AChE in the micromolar concentration range (IC = 7-50 µM). For the most potent inhibitor of BuChE, Cornish-Bowden plots were used, which demonstrated that it behaves as a mixed inhibitor. Modelling studies of the same inhibitor demonstrated that the benzotriazole and 1-deoxynojirimycin moiety is accommodated in the peripheral anionic site and catalytic anionic site, respectively, of AChE. The binding mode to BuChE was different as the benzotriazole moiety is accommodated in the catalytic anionic site.

摘要

本文报道了四种杂二聚体的合成,其中采用铜(I)催化的叠氮-炔环加成反应将 1-脱氧野尻霉素部分与苯并三唑支架连接。这些杂二聚体被用作乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)的抑制剂进行了研究。在微摩尔浓度范围内(IC = 7-50 μM),杂二聚体对 BuChE 的抑制作用优先(> 9)。对于 BuChE 的最有效抑制剂,使用了 Cornish-Bowden 图,表明它表现为混合抑制剂。对相同抑制剂的建模研究表明,苯并三唑和 1-脱氧野尻霉素部分分别容纳在 AChE 的外周阴离子部位和催化阴离子部位中。与 BuChE 的结合模式不同,因为苯并三唑部分容纳在催化阴离子部位中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/731f1afea811/IENZ_A_2117912_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/0f2255dd3f41/IENZ_A_2117912_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/65800fde7550/IENZ_A_2117912_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/d49dff5f8b62/IENZ_A_2117912_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/4b9e031068af/IENZ_A_2117912_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/3d85f7772354/IENZ_A_2117912_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/731f1afea811/IENZ_A_2117912_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/0f2255dd3f41/IENZ_A_2117912_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/65800fde7550/IENZ_A_2117912_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/d49dff5f8b62/IENZ_A_2117912_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/4b9e031068af/IENZ_A_2117912_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/3d85f7772354/IENZ_A_2117912_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/9467581/731f1afea811/IENZ_A_2117912_F0005_C.jpg

相似文献

1
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE).1-去氧野尻霉素和苯并三唑的混合物优先诱导丁酰胆碱酯酶(BuChE)的抑制,而不是乙酰胆碱酯酶(AChE)。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2395-2402. doi: 10.1080/14756366.2022.2117912.
2
Analogues of 2'-hydroxychalcone with modified C4-substituents as the inhibitors against human acetylcholinesterase.具有修饰的 C4-取代基的 2'-羟基查耳酮类似物作为人乙酰胆碱酯酶抑制剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):130-137. doi: 10.1080/14756366.2020.1847100.
3
Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers.手性吖啶酮-亚氨基糖杂合二聚体对乙酰胆碱酯酶和丁酰胆碱酯酶抑制的对映选择性研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):349-360. doi: 10.1080/14756366.2022.2150762.
4
2-Hydroxy--phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase.2-羟基-苯基苯甲酰胺及其酯类抑制乙酰胆碱酯酶和丁酰胆碱酯酶。
Biomolecules. 2019 Nov 5;9(11):698. doi: 10.3390/biom9110698.
5
Tuning the activity of iminosugars: novel -alkylated deoxynojirimycin derivatives as strong BuChE inhibitors.调变亚胺糖的活性:新型烷基化去氧野尻霉素衍生物作为强效 BuChE 抑制剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):138-146. doi: 10.1080/14756366.2020.1847101.
6
Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.新型他克林-靛红席夫碱杂合衍生物的设计、合成与生物活性。
Bioorg Chem. 2019 Aug;89:103006. doi: 10.1016/j.bioorg.2019.103006. Epub 2019 May 21.
7
Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.基于药效基团、3D-QSAR 和分子对接方法评价新型双重乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂作为潜在的抗阿尔茨海默病药物。
Molecules. 2017 Jul 26;22(8):1254. doi: 10.3390/molecules22081254.
8
Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.新型异黄酮衍生物作为乙酰胆碱酯酶/丁酰胆碱酯酶双靶点抑制剂的发现:合成、生物学评价及分子模拟
J Enzyme Inhib Med Chem. 2017 Dec;32(1):968-977. doi: 10.1080/14756366.2017.1347163.
9
Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.新型褪黑素-他克林杂合二聚体对丁酰胆碱酯酶的高选择性抑制。
J Pineal Res. 2013 May;54(4):435-41. doi: 10.1111/jpi.12006.
10
Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.新型联苯/联苄基衍生物作为乙酰胆碱酯酶和丁酰胆碱酯酶双重抑制剂的设计、合成及生物学评价
Molecules. 2017 Jan 20;22(1):172. doi: 10.3390/molecules22010172.

引用本文的文献

1
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration.一种针对神经炎症的多靶点方法:烷基取代香豆素作为参与神经退行性变的酶的抑制剂
Antioxidants (Basel). 2023 Nov 25;12(12):2044. doi: 10.3390/antiox12122044.
2
Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers.手性吖啶酮-亚氨基糖杂合二聚体对乙酰胆碱酯酶和丁酰胆碱酯酶抑制的对映选择性研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):349-360. doi: 10.1080/14756366.2022.2150762.

本文引用的文献

1
Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer's disease.色满衍生物的评估:阿尔茨海默病中具有前景的先导发现的优势骨架。
Bioorg Med Chem. 2022 Aug 15;68:116807. doi: 10.1016/j.bmc.2022.116807. Epub 2022 May 9.
2
Controversial Alzheimer's drug approval could affect other diseases.有争议的阿尔茨海默病药物获批可能会影响其他疾病。
Nature. 2021 Jul;595(7866):162-163. doi: 10.1038/d41586-021-01763-9.
3
Landmark Alzheimer's drug approval confounds research community.具有里程碑意义的阿尔茨海默病药物获批令研究界感到困惑。
Nature. 2021 Jun;594(7863):309-310. doi: 10.1038/d41586-021-01546-2.
4
Tacrine-sugar mimetic conjugates as enhanced cholinesterase inhibitors.他克林糖模拟缀合物作为增强的胆碱酯酶抑制剂。
Org Biomol Chem. 2021 Mar 18;19(10):2322-2337. doi: 10.1039/d0ob02588g.
5
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.萘醌和蒽醌衍生物的研究历程:阿尔茨海默病的新见解
Pharmaceuticals (Basel). 2021 Jan 5;14(1):33. doi: 10.3390/ph14010033.
6
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease.针对阿尔茨海默病的新型萘醌和蒽醌类衍生物的多靶点生物特征分析。
ACS Chem Neurosci. 2021 Feb 3;12(3):447-461. doi: 10.1021/acschemneuro.0c00624. Epub 2021 Jan 11.
7
Tuning the activity of iminosugars: novel -alkylated deoxynojirimycin derivatives as strong BuChE inhibitors.调变亚胺糖的活性:新型烷基化去氧野尻霉素衍生物作为强效 BuChE 抑制剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):138-146. doi: 10.1080/14756366.2020.1847101.
8
New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.新型香豆素-苯并三唑类杂化分子作为乙酰胆碱酯酶和淀粉样蛋白聚集抑制剂。
Bioorg Med Chem Lett. 2020 Oct 15;30(20):127477. doi: 10.1016/j.bmcl.2020.127477. Epub 2020 Aug 8.
9
Current and Future Treatments in Alzheimer Disease: An Update.阿尔茨海默病的当前及未来治疗方法:最新进展
J Cent Nerv Syst Dis. 2020 Feb 29;12:1179573520907397. doi: 10.1177/1179573520907397. eCollection 2020.
10
New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.新证据表明,乙酰胆碱酯酶双重结合位点抑制剂可作为治疗阿尔茨海默病的改良药物。
Neuropharmacology. 2019 Sep 1;155:131-141. doi: 10.1016/j.neuropharm.2019.05.025. Epub 2019 May 25.